Results from a Model to Forecast The Current and Future Number of Patients Eligible for Treatment of Refractory Advanced Non-Small Cell Lung Cancer (NSCLC) in France, Germany, Italy and Spain
Abstract
Authors
DJ Campbell K O'Day JR Penrod J Kish M Manley Daumont N Hertel